What is EP Biocomposites Ltd (543595) share price return in the past 10 years?

Data is not available for this company

What is the share price of EP Biocomposites Ltd (543595)?

Company share prices are keep on changing according to the market conditions. The current trading price of EP Biocomposites Ltd (543595) on 04-Jun-2026 16:59:59 at 16:59 is 94.00.

What is the P/E ratio of EP Biocomposites?

The latest standalone P/E ratio of EP Biocomposites as of 04-Jun-2026 is 10.83.

What is the P/B ratio of EP Biocomposites Ltd (543595)?

The latest standalone P/B ratio of EP Biocomposites Ltd (543595) as of 04-Jun-2026 is 1.49.

What is the 52-week high and low of EP Biocomposites Ltd (543595)?

The 52-week high of EP Biocomposites Ltd (543595) is Rs. 149.90 and the 52-week low is Rs. 75.50.

EP Biocomposites Ltd (543595) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: EP Biocomposites Ltd (543595)
Brand: EP Biocomposites

EP Biocomposites Ltd (543595)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543595 NSE: Plastic Products | Small Cap | EP Biocomposites Share Price

EP Biocomposites Ltd (543595)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543595 NSE: Plastic Products | Small Cap | EP Biocomposites Share Price

Key Metrics

Valuation Multiples

Market Cap

₹16 Cr.

Current Price

₹94

52-Week Low / High

₹76 / 150

TTM EPS

₹8.7

TTM Sales

₹13.6 Cr.

Book Value per Share

₹63

P/E Ratio

10.83

Lower than its 5-year historical median

Industry PE

Price to Book (P/B)

1.49

Lower than its 5-year historical median

Price to Sales (P/S)

1.16

Lower than its 5-year historical median

EV/EBITDA

7.22

Lower than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

10.23%

Outperforms industry median

Return on Capital Employed (ROCE)

14.24%

Outperforms industry median

Return on Assets (ROA)

6.51%

Operating Profit Margin

14.8%

Net Profit Margin

8.59%

Gross Profit Margin

12.7%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

4.98%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

26.24%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-10.43%

Asset Quality

Promoter Holding

70.08%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹9 Cr.

Equity

₹1.7 Cr.

Face Value

₹10

All Time Low / High

₹75.50 / 364.25

EP Biocomposites stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is EP Biocomposites Ltd a good quality company?

EP Biocomposites Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does EP Biocomposites Ltd performance compare with that of its Peers?

Q.1 Revenue growth of EP Biocomposites Ltd vs industry peers?

EP Biocomposites Ltd revenue CAGR is 83.96%, compared to the industry median CAGR of 4.71%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of EP Biocomposites Ltd?

Promoters hold 70.08% of the EP Biocomposites Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of EP Biocomposites Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of -21.7% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	0%	0%	0%	0%	140%	223%	41.8%	13.2%	15.3%	14.2%	-
Value Creation Index ⓘ	NA	NA	NA	NA	9.0	14.9	2.0	-0.1	0.1	0.0	-
Growth Parameters ⓘ
Sales ⓘ	0	0	0	0	0.6	3	8.1	7.1	11.4	12	14
Sales YoY Gr.	-	NA	NA	NA	NA	417.5%	173.2%	-11.5%	60.5%	5%	-
Adj EPS ⓘ	0	0	0	0	0.8	9.6	6.9	3.4	6.8	6.1	8.7
YoY Gr.	-	NA	NA	NA	NA	1036.9%	-28.1%	-50.1%	99.4%	-10.4%	-
BVPS (₹) ⓘ	0	0	0	0	0.8	10.3	17	50	56.9	63	63
Adj Net Profit ⓘ	0	0	0	0	0	0.4	0.8	0.6	1.2	1	1
Cash Flow from Ops. ⓘ	0	0	0	0	0.1	0	-4.3	-0.8	-1.2	-0.5	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	-1	-1.6	-1.5	-6.1	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	84%	14.2%	5%
Adj EPS ⓘ	NA	48.8%	-3.7%	-10.4%
BVPSⓘ	NA	142%	54.9%	10.8%
Share Price	-	-	-21.2%	-17.5%

Key Financial Parameters ⓘ

	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	110.5	172.5	67.9	11.1	12.8	10.2	13.8
Op. Profit Mgn % ⓘ	7.6	15.7	17.5	13.7	12.3	14.8	NAN
Net Profit Mgn % ⓘ	5.5	12.1	10	8.1	10.1	8.6	10.7
Debt to Equity ⓘ	0.1	0	2.1	0.2	0.2	0.3	-
Working Cap Days ⓘ	0	100	224	458	359	425	0
Cash Conv. Cycle ⓘ	0	16	136	278	190	247	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0.57	2.95	8.06	7.13	11.44	12.01
Operating Expenses ⓘ +	0.52	2.49	6.65	6.15	10.03	10.23
Manufacturing Costs	0.06	0.39	0.02	0.02	0.02	0.03
Material Costs	0.42	1.42	4.96	4.10	7.50	7.72
Employee Cost	0.01	0.41	0.96	1.10	1.40	1.39
Other Costs ⓘ	0.04	0.25	0.71	0.94	1.12	1.09
Operating Profit ⓘ	0.04	0.46	1.41	0.98	1.41	1.78
Operating Profit Margin (%)	7.6%	15.7%	17.5%	13.7%	12.3%	14.8%
Other Income ⓘ +	0	0	0.02	0.17	0.30	0.11
Exceptional Items ⓘ	0	0	0	0	0	0
Interest ⓘ	0	0	0.19	0.23	0.04	0.36
Depreciation ⓘ	0	0	0.07	0.10	0.10	0.11
Profit Before Tax ⓘ	0.04	0.46	1.17	0.81	1.57	1.42
Tax ⓘ	0.01	0.11	0.36	0.24	0.42	0.39
Profit After Tax	0.03	0.36	0.81	0.58	1.15	1.03
PAT Margin (%)	5.5%	12.1%	10.0%	8.1%	10.1%	8.6%
Adjusted EPS (₹)	0.8	9.6	6.9	3.4	6.8	6.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%

Valuation of EP Biocomposites - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	0.03	0.39	2	8.41	9.56	10.59
Share Capital ⓘ	0.05	0.05	1.18	1.68	1.68	1.68
Reserves ⓘ	-0.02	0.34	0.82	6.73	7.88	8.91
Debt +	0	0	4.05	1.20	1.80	2.45
Long Term Debt	0	0	2.18	1.20	1.10	2.45
Short Term Debt	0	0	1.87	0	0.70	0
Minority Interest	0	0	0	0	0	0
Trade Payables	0.46	0.64	2.20	1.18	2.94	2.07
Others Liabilities ⓘ	0.06	0.29	1.04	0.92	0.76	1.49
Total Liabilities ⓘ	0.55	1.32	9.28	11.72	15.07	16.61
Fixed Assets
Net Fixed Assets ⓘ +	0	0	0.41	0.33	0.33	0.23
Gross Block	0	0	0.48	0.50	0.60	0.59
Accumulated Depreciation	0	0	0.07	0.17	0.27	0.36
CWIP ⓘ	0	0	0	0	0.14	0.14
Investments ⓘ	0	0	0	0	0	0
Inventories	0.11	0.45	1.18	1.02	1.03	1.41
Trade Receivables	0.30	0.65	7.10	5.86	9	10.86
Cash Equivalents	0.12	0.15	0.16	2.19	1.27	1.62
Others Assets ⓘ	0.02	0.08	0.43	2.32	3.29	2.36
Total Assets ⓘ	0.55	1.32	9.28	11.72	15.07	16.61

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0.12	0.03	-4.28	-0.79	-1.24	-0.49
PBT ⓘ	0.04	0.46	1.17	0.81	1.57	1.42
Adjustment ⓘ	0	-0	0.22	0.26	0.06	0.44
Changes in Working Capital ⓘ	0.07	-0.42	-5.5	-1.5	-2.47	-1.86
Tax Paid ⓘ	0	-0.01	-0.16	-0.36	-0.41	-0.48
Cash Flow From Investing Activity ⓘ +	0	0	-0.47	0.02	-0.16	0.02
Capex	0	-0	-0.47	-0.02	-0.10	-0.01
Net Investments	0	0	0	0	0	0
Others ⓘ	0	0	0.01	0.04	-0.06	0.03
Cash Flow From Financing Activity ⓘ +	-0	-0	4.76	2.81	0.49	0.82
Net Proceeds from Shares ⓘ	0.05	0	0.80	6.35	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	-0.10	1.35
Interest Paid ⓘ	0	0	-0.16	-0.20	-0.03	-0.35
Dividend Paid ⓘ	0	0	0	0	0	0
Others ⓘ	-0.05	-0	4.11	-3.34	0.62	-0.17
Net Cash Flow ⓘ	0.12	0.03	0.01	2.04	-0.92	0.35

Financial Ratio

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	110.53	172.53	67.88	11.07	12.79	10.23
ROCE (%)	140	222.95	41.82	13.21	15.28	14.24
Asset Turnover Ratio	1.03	3.14	1.52	0.68	0.85	0.76
PAT to CFO Conversion(x)	4	0.08	-5.28	-1.36	-1.08	-0.48
Working Capital Days
Receivable Days	194	58.80	175.30	331.60	237.10	301.80
Inventory Days	71.50	34.70	37	56.30	32.70	37.20
Payable Days	406.80	142	104.50	150.40	100.30	118.40

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

EP Biocomposites Ltd FAQs

The current trading price of EP Biocomposites on 04-Jun-2026 16:59 is ₹94.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of EP Biocomposites stood at ₹15.81 Cr

The latest P/E ratio of EP Biocomposites as of 03-Jun-2026 is 10.83.

The latest P/B ratio of EP Biocomposites as of 03-Jun-2026 is 1.49.

The 52-week high of EP Biocomposites is ₹149.9 and the 52-week low is ₹75.50.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of EP Biocomposites is ₹13.64 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that EP Biocomposites Ltd is a average quality company.

The key valuation ratios of EP Biocomposites Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of EP Biocomposites Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About EP Biocomposites Ltd

The company was incorporated as ‘EP Biocomposites Limited’ on January 17, 2020 under the Companies Act, 2013 with the Registrar of Companies, Goa Registration No.014240. A certificate of incorporation was issued on January 17, 2020 by the Registrar of Companies, Goa.

The company was incorporated on January 17, 2020 and is into manufacturing and supply of fibre re-inforced polymers (FRP) products such as door shutters, frames, Biodigestor Tanks, Bio toilets and allied products for construction and Industrial applications which meets customer requirements. The company got into highly potential sector of waste water recycling in 2021. The company has taken over the running business of it promoter, Om Ventures, a sole proprietorship through a business transfer agreement dated August 31, 2021.

The company focuses on giving sanitation solutions to those who do not have access to toilets, as well as to those who have toilets but face trouble treating and managing the waste through septic tanks. It provides sanitation infrastructure and human waste management solutions and services, involving innovative and simple bio-digester technology licensed from Defence Research and Development Organisation (DRDO) and Industry Interface and Technology Management, operating under the aegis of DRDO, Ministry of Defence, Government of India. The anaerobic bio-digester technology helps users manage waste onsite, without depending on expensive and energy-consuming sewage infrastructure.

Business area of the company

EP Biocomposites is the manufacturer and supplier of fibre reinforced polymers (FRP) products such as door shutters, frames, Biodigestor Tanks, Bio toilets and allied products for construction and Industrial applications which meets customer requirements.

Key Events

January, 2020: Incorporation of Company.
August, 2021: Takeover of Proprietorship Concern pursuant to Business Takeover Agreement dated August 31, 2021.

EP Biocomposites Ltd (543595)

EP Biocomposites Ltd (543595)

EP Biocomposites stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of EP Biocomposites - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

EP Biocomposites Ltd FAQs

About EP Biocomposites Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

EP Biocomposites Ltd (543595)

EP Biocomposites Ltd (543595)

EP Biocomposites stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of EP Biocomposites - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

EP Biocomposites Ltd FAQs

What is the share price of EP Biocomposites?

What is the market cap of EP Biocomposites?

What is the P/E ratio of EP Biocomposites?

What is the P/B ratio of EP Biocomposites?

What is the 52-week high and low of EP Biocomposites?

What is the TTM revenue of EP Biocomposites?

Is EP Biocomposites Ltd a good quality company?

Is EP Biocomposites Ltd undervalued or overvalued?

Is EP Biocomposites Ltd a good buy now?

About EP Biocomposites Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.